Literature DB >> 27435618

Causes of liver disease and its outcome in HIV-infected individuals.

Suryanarayana Bettadpura Shamanna1, Ramavath Raghu Ramulu Naik2, Abdoul Hamide3.   

Abstract

Liver disease in HIV-infected patients has remained unaddressed in India. This study describes the causes of liver disease in HIV-infected patients and short-term outcome in them. Designed as a prospective observational study, it was conducted at Jawaharlal Institute of Postgraduate Medical Education and Research between September 2011 and March 2013. All consecutive HIV patients (>13 years) attending the antiretroviral therapy clinic or admitted in the Medicine Department were screened, and patients with liver disease or with either HBsAg or anti-HCV antibody positivity were included in the study. Of the 198 patients screened, 51 (26 %) had either abnormal liver function test or had HBsAg or anti-HCV positivity. The median age of the patients was 40 years and 82 % were males. The median CD4 count was 123 cells/mm(3). Eighteen (35 %) of them had alcoholic liver disease. Six patients had probable hepatic involvement due to tuberculosis. Ten patients had antituberculosis drug-induced hepatotoxicity. One patient had acute hepatitis B and seven patients had chronic hepatitis B. The cause could not be established in 10 patients (20 %). After a median period of 8 months of follow up, 23 patients had improved, 19 patients (37 %) had died, and six patients had been lost to follow up. Of the patients who had died, 11 patients (58 %) had tuberculosis, and 6 patients (30 %) had decompensated alcoholic liver disease. In conclusion, liver disease in HIV-infected patients was associated with high mortality. Alcohol abuse, tuberculosis, and antituberculosis drugs were the major causes.

Entities:  

Keywords:  HIV; Liver disease; Outcome; Resource limited

Mesh:

Substances:

Year:  2016        PMID: 27435618     DOI: 10.1007/s12664-016-0676-6

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  17 in total

1.  Mortality for liver disease in patients with HIV infection: a cohort study.

Authors:  M Puoti; A Spinetti; A Ghezzi; F Donato; S Zaltron; V Putzolu; E Quiros-Roldan; B Zanini; S Casari; G Carosi
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

2.  Long-term outcome of HIV-infected patients treated at a tertiary care hospital in southern India.

Authors:  Abdoul Hamide; Suryanarayana Bettadpura Shamanna; Sridhar Balaguru; Murugavel Subbian
Journal:  Natl Med J India       Date:  2014 May-Jun       Impact factor: 0.537

Review 3.  Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

Authors:  Antonio Rivero; José A Mira; Juan A Pineda
Journal:  J Antimicrob Chemother       Date:  2007-01-25       Impact factor: 5.790

4.  Hepatitis B virus co-infection in HIV infected patients.

Authors:  A Sud; J Singh; R K Dhiman; A Wanchu; S Singh; Y Chawla
Journal:  Trop Gastroenterol       Date:  2001 Apr-Jun

Review 5.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

6.  Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients.

Authors:  Swati Gupta; Sarman Singh
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

7.  Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis.

Authors:  Maria de Fátima Silva de Lima; Heloísa Ramos Lacerda de Melo
Journal:  Cad Saude Publica       Date:  2012-04       Impact factor: 1.632

Review 8.  Hepatotoxicity of antiretroviral therapy.

Authors:  Nickolas Kontorinis; Douglas Dieterich
Journal:  AIDS Rev       Date:  2003 Jan-Mar       Impact factor: 2.500

9.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.

Authors:  Shanmugam Saravanan; Vijayakumar Velu; Nagalingeswaran Kumarasamy; Subhadra Nandakumar; Kailapuri Gangatharan Murugavel; Pachamuthu Balakrishnan; Solomon Suniti; Sadras Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

10.  Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study.

Authors:  Alima Hassen Ali; Tefera Belachew; Alemeshet Yami; Wubeante Yenet Ayen
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more
  2 in total

1.  Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.

Authors:  P Puri; P K Sharma; A Lolusare; V K Sashindran; S Shrivastava; A K Nagpal
Journal:  J Clin Exp Hepatol       Date:  2016-12-29

2.  HLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians.

Authors:  Zelalem Petros; Junko Kishikawa; Eyasu Makonnen; Getnet Yimer; Abiy Habtewold; Eleni Aklillu
Journal:  Front Pharmacol       Date:  2017-02-27       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.